ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Lamisil 250 mg, Tabletten - 14 Tablette(n)
51306015 Novartis Pharma Schweiz AG
Lamisil 250 mg, Tabletten27.08.1991
Original27.08.1991
Terbinafine (D01BA02)21.12.2005
WHO-DDD 
08.06.14 Tablette(n)
08.06. 
B  
Yes 
IPCI
35.78No
    
20 %57.55
7680513060154Synthetika
1434580 
Composition
terbinafinum 250 mg ut terbinafini hydrochloridum, magnesii stearas, hypromellosum, silica colloidalis anhydrica, carboxymethylamylum natricum A corresp. natrium max. 1.9 mg, cellulosum microcristallinum pro compresso.
Packungsbestandteile
Tablets 
 
Active AgentDose
Terbinafine250 mg
BAG: Active AgentDose
Terbinafine250 mg
 
Inactive agents
Carboxymethylamylum Natricum A
Cellulosum Microcristallinum pro Compresso
Hypromellosum
Magnesii Stearas
Silica Colloidalis Anhydrica
 
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home